Top HIV/AIDS drugs worldwide based on revenue 2016-2018

Globally, the top drug for the treatment of HIV/AIDS in 2018 was Genvoya, marketed by Gilead. Genvoya generated over 4.6 billion U.S. dollars in revenue. Truvada, also marketed by Gilead, generated three billion U.S. dollars in revenue. Gilead is the drug manufacturer most specialized in developing drugs for the treatment of HIV/AIDS.

HIV/AIDS cases worldwide

HIV is a virus that attacks the immune system, leading to an increased risk of infections and can lead to death. HIV/AIDS first appeared in global populations in the 1980s. According to current estimates, the prevalence of HIV is highest in low and middle income countries. Swaziland, followed by Lesotho had the highest rates of HIV infections in 2017. The number of new HIV infections yearly is highest among residents of South Africa.

Access to HIV/AIDS treatment

Effective treatment for HIV was not available until the early 1990s. Access to therapy has increased since the early 2000s, and as of 2017 there were almost 22 million people that had access to antiretroviral therapy. Among countries around the world, Uganda, India and Kenya, to name a few, have the lowest rates of access to antiretroviral medications for the treatment of HIV/AIDS. Meanwhile, trends indicate that children living with HIV in Asia or the Pacific have some of the highest rates of access to antiretroviral therapy globally.

Selected top HIV/AIDS drugs worldwide based on revenue from 2016 to 2018

201620172018
----
----
----
----
----
----
----
----
----
----
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

May 2019

Region

Worldwide

Survey time period

2016 to 2018

Supplementary notes

* Converted from British pounds, exchange rate as of December 31 of each year.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Global HIV/AIDS epidemic"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.